News Posts List
Evaluation of neuroendocrine markers in renal cell carcinoma
05/27/2010
Tumours with an immunopositivity for serotonin had a longer RCCspecific survival and tumours with an immunopositivity for CD56 and NSE had a shorter RCCspecific survival but the difference was not significant.
Pfizer Oncology to Present New Clinical Data From Ten Molecules Across Multiple Tumor Type
05/27/2010
Pfizer Oncology (NYSE: PFE) will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets.
Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis - Abstract
05/25/2010
Department of Urology, University of Munich, Klinikum Grosshadern, Marchioninistr. 15, 81377, Munchen, Germany.
Differential diagnosis of renal tumours with clear cell histology - Abstract
05/25/2010
Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up
05/25/2010
Clinical studies have confirmed that renal oncocytoma (RO) is a benign neoplasm with excellent prognosis. In diagnostically challenging cases of renal oncocytic epithelial neoplasms, fluorescent in-situ hybridization (FISH) is increasingly being used and its ability to distinguish RO from chromophobe renal cell carcinoma (ChRCC) has been documented.
Using personalized vaccines, researchers enlist the immune system to oust tumors
05/25/2010
The diagnosis of kidney cancerrenal cell carcinomawas shocking, Creel says.
Leptomeningeal Carcinomatosis From Renal Cell Cancer: Treatment Attempt With Radiation And Sunitinib
05/24/2010
The authors describe the case of leptomeningeal carcinomatosis in a 72-year-old male with known brain and lung metastases from renal cell cancer without previous systemic therapy.
Lappin helped 'Make-A-Wish' dreams come true
05/24/2010
After Todd Lappin was diagnosed with cancer he would tell people that the kidney doctors removed was never his favorite kidney.
AVEO Pharma (AVEO) To Present Data from Tivozanib and AV-299 at ASCO 2010 Annual Meeting
05/22/2010
We are pleased to have the opportunity to present additional analyses from our Phase 2 clinical trial of tivozanib in patients with renal cell cancer, as well as data from a Phase 1 clinical trial of AV-299 in collaboration with Merck . . .
Morphology, Attenuation, Size, and Structure (MASS) Criteria: Assessing Response and Predicting Clinical Outcome in Metastatic Renal Cell Carcinoma on Antiangiogenic Targeted Therapy
05/22/2010
The objective of our study was to evaluate response assessment and predict clinical outcome in patients with metastatic renal cell carcinoma (RCC) receiving antiangiogenic targeted therapy. Target lesions were assessed on routine contrast-enhanced CT (CECT) images obtained during the portal venous phase using new response criteria.
News Feed